Molecular subtyping of leiomyosarcoma with 3′ end RNA sequencing

Leiomyosarcoma (LMS) is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for LMS. We performed expression profiling on 99 cases of LMS with 3′ end RNA sequencing (3SEQ) and demonstrated the existence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiangqian, Forgó, Erna, van de Rijn, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Data in Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521214/
https://www.ncbi.nlm.nih.gov/pubmed/26240788
http://dx.doi.org/10.1016/j.gdata.2015.06.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521214/
https://www.ncbi.nlm.nih.gov/pubmed/26240788
http://dx.doi.org/10.1016/j.gdata.2015.06.029

Ejemplares similares